Melanoma patients with high and low target expression can benefit from TCR-CD3 bispecifics through direct and indirect mechanisms of tumor controlEsra Guc, Anna Broomfield, Sang S. Seo, Aleksandra Raczka, Alex Greenshields-Watson,Laura Collins,Adel BenlahrechCANCER RESEARCH(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要